The Association of Trial Lawyers of America is joining with other consumer groups in voicing anger over a provision in a law passed by Congress this week that gives immunity to drug companies producing flu vaccines.
"Instead of ensuring that Americans can get safe vaccines in the case of a flu outbreak, they instead chose to give sweeping immunity to the big drug companies," said Ken Suggs, president of the Association of Trial Lawyers of America (ATLA).
Insurance industry trade groups would not comment on the issue, which consumer groups and health care industry advocacy group officials first said was being considered by congressional leaders early this week.
The provision is included in a Defense Department appropriations conference report passed by the Senate Wednesday night, which is scheduled for House passage Thursday.
The provision was inserted into the conference report by Senate Majority Leader Willliam Frist, R-Tenn., after House and Senate negotiators had already signed the report and announced its details to the public–something Roll Call reported Tuesday was without "any precedent" after searching the Congressional Research Service guides, Mr. Suggs said.
He noted that Sen. Frist also claimed vaccine manufacturers "would not produce vaccines without liability protections, even though multiple drug companies including Merck, Wyeth, Novartis and Sanofi Pasteur are investing in vaccine production at a rapid pace–without any liability protections."
Mr. Suggs said that "Sanofi Pasteur, for example, already accepted a $100 million contract from the federal government to produce avian flu vaccine. Ensuring that the American people are protected against a pandemic flu outbreak should be a top priority of the government."
He added that the best way to protect Americans "is to produce safe vaccines, not provide the big drug companies with special and unwarranted immunity. Eliminating the right of individuals to hold negligent drug companies accountable removes an important incentive for drug companies to make safe drugs–especially considering that some big drug companies have a track record of putting their profits before the health and safety of the public," Mr. Suggs said.
Want to continue reading?
Become a Free PropertyCasualty360 Digital Reader
Your access to unlimited PropertyCasualty360 content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking insurance news and analysis, on-site and via our newsletters and custom alerts
- Weekly Insurance Speak podcast featuring exclusive interviews with industry leaders
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the employee benefits and financial advisory markets on our other ALM sites, BenefitsPRO and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.